Does the determination of the Bb vitamin D receptor genotype identify psoriasis vulgaris patients responsive to topical tacalcitol?
Giomi
Barbara
B
Ruggiero
Marco
M
Fabbri
Paolo
P
Gulisano
Massimo
M
Peruzzi
Benedetta
B
Caproni
Marzia
M
Pacini
Stefania
S
D000287:Administration, Topical; D000483:Alleles; D002986:Clinical Trials as Topic; D003879:Dermatologic Agents / Q000008:administration & dosage* / Q000494:pharmacology; D004100:Dihydroxycholecalciferols / Q000008:administration & dosage* / Q000494:pharmacology; D005787:Gene Frequency; D005838:Genotype; D006720:Homozygote; D006801:Humans; D011110:Polymorphism, Genetic; D011565:Psoriasis / Q000188:drug therapy* / Q000235:genetics*; D018167:Receptors, Calcitriol / Q000235:genetics*; D016896:Treatment Outcome
D003879:Dermatologic Agents; D004100:Dihydroxycholecalciferols; D018167:Receptors, Calcitriol; C023850:1 alpha,24-dihydroxyvitamin D3